Sign inJoin waitlistJoin the waitlist

Amrita Krishnan

Hematologist · City of Hope National Medical Center

Credentials: · · ·

History

City of Hope National Medical Center
Present

Hematology
1993–1994
Internal Medicine
1990–1993
Doctor of Medicine
1986–1990

Research

Initial genome sequencing and analysis of multiple myeloma
Nature · 2011 · 1,207 citations
Teclistamab in Relapsed or Refractory Multiple Myeloma
New England Journal of Medicine · 2022 · 1,060 citations
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
The Lancet · 2016 · 711 citations

Stephen Forman
54 papers
AN
Auayporn Nademanee
29 papers
Parameswaran Hari
28 papers
GS
George Somlo
25 papers
Henry Fung
22 papers
Sagar Lonial
21 papers
Ajai Chari
20 papers
Edward Stadtmauer
20 papers
Saad Usmani
20 papers
SG
Sergio Giralt
19 papers
David Vesole
18 papers
Shaji Kumar
18 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $337.3K · University of Southern California
1998–2009

Clinical trials

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
Principal investigator · Active not recruiting · Phase 3
SWOG Cancer Research Network
2019–2040
Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
Principal investigator · Active not recruiting · Phase 2
City of Hope Medical Center
2019–2027
Daratumumab, Bortezomib, Dexamethasone, Pegylated Liposomal Doxorubicin Hydrochloride, and Lenalidomide in Treating Participants With Plasma Cell Leukemia
Principal investigator · Withdrawn · Phase 1
City of Hope Medical Center
2018–2019
Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma
Principal investigator · Completed · Phase 1
City of Hope Medical Center
2018–2023